Christopher J. Morl
2016
In 2016, Christopher J. Morl earned a total compensation of $757.5K as Chief Business Officer at Deciphera Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $33,000 |
|---|---|
| Option Awards | $625,849 |
| Salary | $80,000 |
| Other | $18,637 |
| Total | $757,486 |
Morl received $625.8K in option awards, accounting for 83% of the total pay in 2016.
Morl also received $33K in non-equity incentive plan, $80K in salary and $18.6K in other compensation.
Rankings
In 2016, Christopher J. Morl's compensation ranked 9,522nd out of 14,075 executives tracked by ExecPay. In other words, Morl earned more than 32.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,522 out of 14,075 | 32nd |
Division Manufacturing | 3,686 out of 5,489 | 33rd |
Major group Chemicals And Allied Products | 1,279 out of 1,895 | 33rd |
Industry group Drugs | 1,015 out of 1,538 | 34th |
Industry Pharmaceutical Preparations | 799 out of 1,176 | 32nd |
Source: SEC filing on April 3, 2018.
Morl's colleagues
We found one more compensation record of an executive who worked with Christopher J. Morl at Deciphera Pharmaceuticals in 2016.
2016
Michael Taylor
Deciphera Pharmaceuticals